EUVIMEDEUVIMED entdecken
Crossref

Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids

Eleonora Riccobono, Sara Salvetti, Marco Coppi, Iolanda Montenora, Vincenzo Di Pilato iD, Gian Maria Rossolini

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Eleonora Riccobono und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Citrobacter freundii. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To characterize a carbapenem-resistant Citrobacter freundii (Cf-Emp) co-producing class A, B and D carbapenemases, resistant to novel β-lactamase inhibitor combinations (BLICs) and cefiderocol.

Methods

Carbapenemase production was tested by an immunochromatography assay. Antibiotic susceptibility testing (AST) was performed by broth microdilution. WGS was performed using short- and long-read sequencing. Transfer of carbapenemase-encoding plasmids was assessed by conjugation experiments.

Results

Cf-Emp was isolated on selective medium for carbapenem-resistant Enterobacterales from the surveillance rectal swab taken at hospital admission from a patient of Moroccan origin. Cf-Emp produced three different carbapenemases, including KPC-2, OXA-181 and VIM-1, and was resistant to all β-lactams including carbapenems, novel BLICs (ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam) and cefiderocol. MIC of aztreonam/avibactam was 0.25 mg/L. The strain belonged to ST22, one of the C. freundii lineages of global diffusion, known to be associated with carbapenemase production. Each carbapenemase gene was located aboard a different plasmid (named pCf-KPC, pCf-OXA and pCf-VIM, respectively), which also carried other clinically relevant resistance genes, such as armA (pCf-KPC), blaSHV-12 (pCf-VIM) and qnrS1 (pCf-OXA). Transferability to Escherichia coli J53 by conjugation was observed for all plasmids.

Conclusions

The finding of enterobacterial strains carrying multiple carbapenemase genes on transferable plasmids is alarming, because similar strains could provide an important reservoir for disseminating these clinically relevant resistance determinants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Lactamase InhibitorsCitrobacter freundiiHumansBacterial Proteinsbeta-LactamasesAnti-Bacterial AgentsCarbapenemsPlasmidsDrug CombinationsMicrobial Sensitivity TestsCefiderocolAzabicyclo Compounds

Substanzen

beta-Lactamase InhibitorsBacterial Proteinsbeta-LactamasesAnti-Bacterial AgentsCarbapenemsDrug CombinationsCefiderocolcarbapenemaseavibactamAzabicyclo Compounds

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Microbiology Unit, San Giuseppe Hospital, Empoli, Florence, Italy.
  • Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
  • Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.

ORCID-Profile: Vincenzo Di Pilato

Förderung

  • Italian Ministry of Health

Zitieren

APA

Riccobono, E., Salvetti, S., Coppi, M., Montenora, I., Di Pilato, V., & Rossolini, G. M. (2023). Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad150

Vancouver

Riccobono E, Salvetti S, Coppi M, Montenora I, Di Pilato V, Rossolini GM. Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad150

BibTeX
@article{Riccobono2023,
  author = {Riccobono, Eleonora and Salvetti, Sara and Coppi, Marco and Montenora, Iolanda and Di Pilato, Vincenzo and Rossolini, Gian Maria},
  title = {Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad150}
}
Kostenlos starten →